Schwarz Pharma

Schwarz Pharma was a pharmaceutical company known for developing medications, particularly in the area of neurological and psychiatric conditions. Founded in Germany in 1890, it grew to become a global player before being acquired by UCB in 2006. Its work focused on innovative treatments for disorders such as epilepsy and multiple sclerosis. The company's research and products have contributed to improving quality of life for many patients. Today, Schwarz Pharma operates as part of UCB, continuing its legacy of pharmaceutical advancements.